Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 67


Mitral annular plane systolic excursion (MAPSE) in shock: a valuable echocardiographic parameter in intensive care patients.

Bergenzaun L, Ohlin H, Gudmundsson P, Willenheimer R, Chew MS.

Cardiovasc Ultrasound. 2013 May 30;11:16. doi: 10.1186/1476-7120-11-16.


High-sensitive cardiac Troponin T is superior to echocardiography in predicting 1-year mortality in patients with SIRS and shock in intensive care.

Bergenzaun L, Ohlin H, Gudmundsson P, Düring J, Willenheimer R, Chew MS.

BMC Anesthesiol. 2012 Sep 24;12:25. doi: 10.1186/1471-2253-12-25.


Impact of hypoxia, simulated ischemia and reperfusion in HL-1 cells on the expression of FKBP12/FKBP12.6 and intracellular calcium dynamics.

Åström-Olsson K, Li L, Olofsson CS, Borén J, Öhlin H, Grip L.

Biochem Biophys Res Commun. 2012 Jun 15;422(4):732-8. doi: 10.1016/j.bbrc.2012.05.071. Epub 2012 May 19.


The balance of serum matrix metalloproteinase-8 and its tissue inhibitor in acute coronary syndrome and its recurrence.

Pussinen PJ, Sarna S, Puolakkainen M, Öhlin H, Sorsa T, Pesonen E.

Int J Cardiol. 2013 Jul 31;167(2):362-8. doi: 10.1016/j.ijcard.2011.12.095. Epub 2012 Jan 16.


Initial results of inflammatory response, matrix remodeling, and reactive oxygen species following PCI in acute ischemic myocardial injury in man.

Hedström E, Aström-Olsson K, Ohlin AK, Ohlin H, Arheden H.

J Invasive Cardiol. 2011 Sep;23(9):371-6.


Assessing left ventricular systolic function in shock: evaluation of echocardiographic parameters in intensive care.

Bergenzaun L, Gudmundsson P, Öhlin H, Düring J, Ersson A, Ihrman L, Willenheimer R, Chew MS.

Crit Care. 2011 Aug 16;15(4):R200. doi: 10.1186/cc10368.


Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.

Swedberg K, Komajda M, Böhm M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, Tavazzi L; SHIFT Investigators.

Lancet. 2010 Sep 11;376(9744):875-85. doi: 10.1016/S0140-6736(10)61198-1. Erratum in: Lancet. 2010 Dec 11;376(9757):1988. Lajnscak, M [corrected to Lainscak, M]; Rabanedo, I Roldan [corrected to Rabadán, I Roldan]; Leva, M [corrected to Ieva, M].


High-frequency electrocardiogram as a supplement to standard 12-lead ischemia monitoring during reperfusion therapy of acute inferior myocardial infarction.

Pettersson J, Wagner GS, Sörnmo L, Johansson ET, Ohlin H, Pahlm O.

J Electrocardiol. 2011 Jan-Feb;44(1):11-7. doi: 10.1016/j.jelectrocard.2010.04.006. Epub 2010 May 21.


Infarct evolution in man studied in patients with first-time coronary occlusion in comparison to different species - implications for assessment of myocardial salvage.

Hedström E, Engblom H, Frogner F, Aström-Olsson K, Ohlin H, Jovinge S, Arheden H.

J Cardiovasc Magn Reson. 2009 Sep 23;11:38. doi: 10.1186/1532-429X-11-38.


Infections as a stimulus for coronary occlusion, obstruction, or acute coronary syndromes.

Pesonen E, El-Segaier M, Persson K, Puolakkainen M, Sarna S, Ohlin H, Pussinen PJ.

Ther Adv Cardiovasc Dis. 2009 Dec;3(6):447-54. doi: 10.1177/1753944709345598. Epub 2009 Sep 22.


Mannose-binding lectin as a risk factor for acute coronary syndromes.

Pesonen E, Hallman M, Sarna S, Andsberg E, Haataja R, Meri S, Persson K, Puolakkainen M, Ohlin H, Truedsson L.

Ann Med. 2009;41(8):591-8. doi: 10.1080/07853890903110994.


Inequality in treatment use among elderly patients with acute myocardial infarction: USA, Belgium and Quebec.

Perelman J, Shmueli A, McDonald KM, Pilote L, Saynina O, Closon MC; TECH Investigators.

BMC Health Serv Res. 2009 Jul 30;9:130. doi: 10.1186/1472-6963-9-130.


Serum chlamydial lipopolysaccharide as a prognostic factor for a new cardiovascular event.

Pesonen E, Tiirola T, Andsberg E, Jauhiainen M, Paldanius M, Persson K, Saikku P, Sarna S, Ohlin H, Leinonen M.

Heart Lung. 2009 May-Jun;38(3):176-81. doi: 10.1016/j.hrtlng.2008.06.001. Epub 2008 Oct 5.


Elevated infection parameters and infection symptoms predict an acute coronary event.

Pesonen E, Andsberg E, Grubb A, Rautelin H, Meri S, Persson K, Puolakkainen M, Sarna S, Ohlin H.

Ther Adv Cardiovasc Dis. 2008 Dec;2(6):419-24. doi: 10.1177/1753944708098695.


The rationale and design of the PERindopril GENEtic association study (PERGENE): a pharmacogenetic analysis of angiotensin-converting enzyme inhibitor therapy in patients with stable coronary artery disease.

Brugts JJ, de Maat MP, Boersma E, Witteman JC, van Duijn C, Uitterlinden AG, Bertrand M, Remme W, Fox K, Ferrari R, Danser AH, Simoons ML; EUROPA-PERGENE investigators.

Cardiovasc Drugs Ther. 2009 Apr;23(2):171-81. doi: 10.1007/s10557-008-6156-1. Epub 2008 Dec 10.


The influence of economic incentives and regulatory factors on the adoption of treatment technologies: a case study of technologies used to treat heart attacks.

Bech M, Christiansen T, Dunham K, Lauridsen J, Lyttkens CH, McDonald K, McGuire A; TECH Investigators.

Health Econ. 2009 Oct;18(10):1114-32. doi: 10.1002/hec.1417.


In search of the best method to predict acute coronary syndrome using only the electrocardiogram from the emergency department.

Forberg JL, Green M, Björk J, Ohlsson M, Edenbrandt L, Ohlin H, Ekelund U.

J Electrocardiol. 2009 Jan-Feb;42(1):58-63. doi: 10.1016/j.jelectrocard.2008.07.010. Epub 2008 Sep 19.


Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis.

Rossebø AB, Pedersen TR, Boman K, Brudi P, Chambers JB, Egstrup K, Gerdts E, Gohlke-Bärwolf C, Holme I, Kesäniemi YA, Malbecq W, Nienaber CA, Ray S, Skjaerpe T, Wachtell K, Willenheimer R; SEAS Investigators.

N Engl J Med. 2008 Sep 25;359(13):1343-56. doi: 10.1056/NEJMoa0804602. Epub 2008 Sep 2.


Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial.

Fox K, Ford I, Steg PG, Tendera M, Ferrari R; BEAUTIFUL Investigators.

Lancet. 2008 Sep 6;372(9641):807-16. doi: 10.1016/S0140-6736(08)61170-8. Epub 2008 Aug 29.


Supplemental Content

Loading ...
Support Center